HOME >> MEDICINE >> NEWS
Problems at World Anti-Doping Agency will 'drive innocent athletes out of sport'

The current approach of the international agency responsible for fighting the use of drugs in sport will drive innocent athletes out of the Olympic Games, according to an article in the International Journal of Sports Science and Coaching.

The World Anti-Doping Agency (WADA) was set up in 1999 by the International Olympic Committee and publishes the list of banned substances and monitors drug use in sport through random tests.

In a review of some of the practices and procedures used by WADA, a leading sports scientist from the USA and a top marathon coach from the UK have identified major problems that they believe will lead to innocent athletes paying the price for a flawed anti-doping system.

Key to their finding was a lack of scientific evidence and protocol at the heart of WADA's operations.

"Drug testing and classification should be a scientific affair, unfortunately WADA appears to have little to no understanding of the criteria for science," said Dr Brent Rushall from San Diego State University, a four-time Olympic Team psychologist for Canada, who co-wrote the article with Max Jones, a multiple age-group world-record holding runner who has studied the drugs in sport movement.

"The actions and scope of WADA are causes for grave concern for the anti-drugs in sport movement. It is inevitable that if WADA continues its practices, professional athletes will be driven out of the Olympic Games."

Problems identified by the authors include:

  • Substances included in WADA's banned list are based on speculation rather than scientific evidence
  • WADA's clandestine sample collection procedures appear to ignore basic scientific guidelines
  • The way WADA lists banned substances does not conform to usual scientific practice, leading to confusion for coaches and athletes

    The authors cite the hysteria surrounding Anabolic Androgenic Steroids (AAS) as an example of WADA's poor use of science.
    '"/>



  • Contact: Dr Brent Rushall
    brushall@cox.net
    1-619-469-1537
    University of Bath
    17-Feb-2006


    Page: 1 2 3

    Related medicine news :

    1. Worlds largest respiratory health study launches next phase
    2. World first medical treatment announced by researchers
    3. World-leading innovation in child-allergy detection
    4. World-renowned chemist honored with inaugural lectureship
    5. IOF World Congress on Osteoporosis to be held for first time in Asia
    6. World first in medical robotics
    7. Worldwide Parkinsons cases will double in next 25 years
    8. Worldmapper draws attention to the worlds health inequalities
    9. World-class Biomedical Research Center to be in West London
    10. Worlds largest clinical trial into rare bone cancer well underway conference hears
    11. World-wide warning of highly drug-resistant tuberculosis

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:5/27/2017)... ... May 26, 2017 , ... A May 8 ... a doctor for colds or respiratory issues that are not responsive to antibiotics nevertheless ... on doctors may be largely responsible for the problem both in Canada and the ...
    (Date:5/27/2017)... ... 2017 , ... In any business, follow up is critical to success. It ... at presenting treatment, there will always be some patients who can’t or won’t make ... best practices when it comes to presenting treatment. After the patient leaves, most ...
    (Date:5/27/2017)... Santa Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... show cause for concern, but a new study from the Osteoarthritis Initiative ... vulnerable to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity ...
    (Date:5/26/2017)... ... May 26, 2017 , ... ... this week to review more than eighty-nine grant submissions all vying for nearly ... scientists in the Parkinson’s field.     , The American Parkinson Disease Association (APDA) is ...
    (Date:5/26/2017)... ... May 26, 2017 , ... The Radiology ... to focus on current legislative activity and the latest regulatory concerns impacting RBMA ... Sunday, Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, ...
    Breaking Medicine News(10 mins):
    (Date:5/18/2017)... , May 18, 2017  Two Bayer U.S. ... Association (HBA) during its recent 28 th ... City.  The event showcases HBA,s longstanding mission of furthering ... of healthcare. Cindy Powell-Steffen , senior ... U.S. Radiology division, and Libby Howe , a ...
    (Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
    (Date:5/10/2017)... 2017 Hologic, Inc. (Nasdaq: HOLX ... fiscal second quarter ended April 1, 2017 .   ... 666.7% compared to the prior year period as the ... significant gain, while non-GAAP diluted EPS of $0.50 increased ... in constant currency terms.  Excluding the effects of blood ...
    Breaking Medicine Technology:
    Cached News: